Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupert Bauersachs

Showing results (51-60 of 132) with videos related to

Pageof 14
Sort By:
VASA. Zeitschrift Fur Gefasskrankheiten|April 9, 2016
Treatment of pregnancy-associated venous thromboembolism - position paper from the Working Group in Women's Health of the Society of Thrombosis and Haemostasis (GTH)Birgit Linnemann, Ute Scholz, Hannelore Rott, et al.
Hamostaseologie|August 7, 2025
Implications of the API-CAT Trial for Extended Secondary Prophylaxis of Cancer-associated Venous Thromboembolism: Guidance from an Expert PanelFlorian Langer, Christina Hart, Kai-Michael Klima, et al.
BMJ Open|September 13, 2018
Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 studyHolger Reinecke, Sabine Jürgensmeyer, Christiane Engelbertz, et al.
Thrombosis and Haemostasis|November 17, 2020
Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio StudyWalter Ageno, Maria Cristina Vedovati, Ander Cohen, et al.
European Journal of Cancer (Oxford, England : 1990)|March 29, 2021
Effects of concomitant administration of anticancer agents and apixaban or dalteparin on recurrence and bleeding in patients with cancer-associated venous thromboembolismMelina Verso, Andres Munoz, Rupert Bauersachs, et al.
The Oncologist|May 9, 2020
Fundamental Research in Oncology and Thrombosis 2 (FRONTLINE 2): A Follow-Up SurveyAjay K Kakkar, Rupert Bauersachs, Anna Falanga, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 11, 2012
Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patientsThomas Wilke, Antje Groth, Sabrina Mueller, et al.
Vascular Medicine (London, England)|June 7, 2022
Assessment of the burden of disease for patients with peripheral artery disease undergoing revascularization in EnglandLaura Portas, Rupert Bauersachs, Kevin Bowrin, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|March 20, 2016
Post-thrombotic syndrome 3 years after deep venous thrombosis in the Thrombosis and Pulmonary Embolism in Out-Patients (TULIPA) PLUS RegistryViola Hach-Wunderle, Rupert Bauersachs, Horst-Eberhard Gerlach, et al.
Journal of Cardiovascular Pharmacology|November 9, 2020
Country-based Comparison of Atrial Fibrillation Patients' Preferences for Oral Anticoagulation: An Evaluation of Discrete Choice Experiments in Five Different CountriesMaren Henry, Melanie Wosnitza, Inga-Marion Thate-Waschke, et al.
Pageof 14

Showing results (51-60 of 132) with videos related to

Sort By:
Pageof 14
VASA. Zeitschrift Fur Gefasskrankheiten|April 9, 2016
Treatment of pregnancy-associated venous thromboembolism - position paper from the Working Group in Women's Health of the Society of Thrombosis and Haemostasis (GTH)Birgit Linnemann, Ute Scholz, Hannelore Rott, et al.
Hamostaseologie|August 7, 2025
Implications of the API-CAT Trial for Extended Secondary Prophylaxis of Cancer-associated Venous Thromboembolism: Guidance from an Expert PanelFlorian Langer, Christina Hart, Kai-Michael Klima, et al.
BMJ Open|September 13, 2018
Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 studyHolger Reinecke, Sabine Jürgensmeyer, Christiane Engelbertz, et al.
Thrombosis and Haemostasis|November 17, 2020
Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio StudyWalter Ageno, Maria Cristina Vedovati, Ander Cohen, et al.
European Journal of Cancer (Oxford, England : 1990)|March 29, 2021
Effects of concomitant administration of anticancer agents and apixaban or dalteparin on recurrence and bleeding in patients with cancer-associated venous thromboembolismMelina Verso, Andres Munoz, Rupert Bauersachs, et al.
The Oncologist|May 9, 2020
Fundamental Research in Oncology and Thrombosis 2 (FRONTLINE 2): A Follow-Up SurveyAjay K Kakkar, Rupert Bauersachs, Anna Falanga, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 11, 2012
Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patientsThomas Wilke, Antje Groth, Sabrina Mueller, et al.
Vascular Medicine (London, England)|June 7, 2022
Assessment of the burden of disease for patients with peripheral artery disease undergoing revascularization in EnglandLaura Portas, Rupert Bauersachs, Kevin Bowrin, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|March 20, 2016
Post-thrombotic syndrome 3 years after deep venous thrombosis in the Thrombosis and Pulmonary Embolism in Out-Patients (TULIPA) PLUS RegistryViola Hach-Wunderle, Rupert Bauersachs, Horst-Eberhard Gerlach, et al.
Journal of Cardiovascular Pharmacology|November 9, 2020
Country-based Comparison of Atrial Fibrillation Patients' Preferences for Oral Anticoagulation: An Evaluation of Discrete Choice Experiments in Five Different CountriesMaren Henry, Melanie Wosnitza, Inga-Marion Thate-Waschke, et al.
Pageof 14